Abstract:Background: Hereditary transthyretin amyloidosis (ATTR) is an autosomal dominant disease characterized by amyloid fibril deposition. The TTR c.148G > T mutation (V30L) in ATTR is rarely reported, and its biochemical properties are unknown. Methods: Seven patients and two asymptomatic carriers from two unrelated families diagnosed with V30L variant of ATTR were included. Data on clinical manifestations, laboratory examination, electrophysiology, ophthalmological corneal confocal microscopy (CCM), pathology and molecular biological experiments was collected and analyzed. Results: Most patients initially experienced paresthesia, with varying degrees of peripheral neuropathy, autonomic dysfunction, and cardiac involvement. Nerve conduction studies showed extensive motor and sensory nerve involvement in upper and lower limbs. CCM revealed reduced corneal nerve density and fiber length. Sural nerve biopsies indicated loss of myelinated nerve fibers, with neurogenic patterns in gastrocnemius muscle biopsies. Asymptomatic carriers had nearly normal electrophysiology but mild reductions in corneal nerve fiber density and length. Sural nerve biopsies in carriers showed mild reductions in small myelinated nerve fibers. V30L mutation impaired thermodynamic and kinetic stability of the mutant protein. Plasma TTR tetramer concentration was lower in ATTR V30L patients compared to healthy donors. Small molecule stabilizers failed to exhibit satisfactory inhibition on fibril formation of V30L mutation in vitro. Conclusion: This study highlights the multisystem involvement in ATTR V30L patients, including neuropathy and cardiac issues. Both patients and carriers showed abnormalities in nerve conduction, corneal microscopy, and pathology. The V30L mutation impaired protein stability and reduced plasma TTR tetramer levels. Small molecule stabilizers were ineffective, indicating a need for alternative treatments.

Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy

Multi-organ structural homogeneity of amyloid fibrils in ATTRv-T60A amyloidosis patients, revealed by Cryo-EM

Cryo-EM confirms a common fibril fold in the heart of four patients with ATTRwt amyloidosis

Amyloid fibril polymorphism in the heart of an ATTR amyloidosis patient with polyneuropathy attributed to the V122Δ variant

ATTRv-V30M Type A amyloid fibrils from heart and nerves exhibit structural homogeneity

ATTRv-V30M amyloid fibrils from heart and nerves exhibit structural homogeneity

ATTRv-V30M Type A amyloid fibrils from the heart and nerves exhibit structural homogeneity.

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis

Structure-based probe reveals the presence of large transthyretin aggregates in plasma of ATTR amyloidosis patients

Structural Reconstruction of Individual Filaments in Aβ42 Fibril Populations Assembledin Vitroreveal Rare Species That Resembleex Vivoamyloid Polymorphs from Human Brains

Structural Basis for Monoclonal Antibody Therapy for Transthyretin Amyloidosis

Human in vitro disease modeling of ATTR cardiac amyloidosis

Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis

Structural reconstruction of individual filaments in Aβ42 fibril populations assembled in vitro reveal rare species that resemble ex vivo amyloid polymorphs from human brains

Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition

Cryo-EM reveals that cardiac IGLV6-derived AL fibrils can be polymorphic

Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis

A molecular basis for tetramer destabilization and aggregation of transthyretin Ala97Ser

Structures and Dynamics of β-Rich Oligomers of ATTR (105–115) Assembly

Structural and thermodynamic characterization of a highly amyloidogenic dimer of transthyretin involved in a severe cardiomyopathy

Clinical and biochemical characterization of asymptomatic carriers and symptomatic patients with hereditary transthyretin amyloidosis caused by TTR V30L mutation